Loading
Cure-First
Cure-First is a nonprofit that grows organoids from a patient's tumour and screens them against dozens of anticancer drugs, and makes the results available to patients directly.
Overview
Cure-First offers organoid generation from patient tumour tissue and drug screening of more than 47 anticancer agents drawn from a library of over 200, as a nonprofit and patient-accessible service according to Future of Cancer Care Today.
Connected
2Similar pages
- Company2cureX
Shares Functional (ex vivo) drug testing, Patient-derived organoids and the tag fcct-directory.
- CompanySageMedic
Shares Functional (ex vivo) drug testing, Patient-derived organoids and the tag fcct-directory.
- CompanySpeciCare
Shares Functional (ex vivo) drug testing, Patient-derived organoids and the tag fcct-directory.
- CompanyTravera
Shares Functional (ex vivo) drug testing and the tag fcct-directory.
- CompanyKiyatec
Shares Functional (ex vivo) drug testing, Patient-derived organoids and the tag fcct-directory.
- CompanyFirst Ascent Biomedical
Shares Functional (ex vivo) drug testing and the tag fcct-directory.
- CompanyKYAN Technologies
Shares Functional (ex vivo) drug testing and the tag fcct-directory.
- CompanyStoreMyTumor
Shares Functional (ex vivo) drug testing and the tag fcct-directory.
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
cure-first.org · 1
sijbrandijfoundation.org · 1
A source that has moved or gone is reported by the weekly link check. /audit/